XML 113 R43.htm IDEA: XBRL DOCUMENT v3.10.0.1
Financial Instruments - Schedule of Impact that Derivatives not Qualifying as Hedging Instruments in Condensed Consolidated Statements of Operations (Parenthetical) (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2018
Dec. 31, 2017
Sep. 30, 2017
Jun. 30, 2017
Mar. 31, 2017
Dec. 31, 2016
Sep. 30, 2016
Jun. 30, 2016
Mar. 31, 2016
Jun. 30, 2018
Jun. 30, 2017
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Derivative Instruments And Hedging Activities Disclosure [Abstract]                            
Net cash receipts (payments) on settled derivative instruments $ (33,600)     $ 9,200           $ (54,100) $ 13,700      
Price risk management activities income (expense) $ (91,176) [1] $ (84,365) $ (28,086) $ 38,995 [1] $ 45,893 $ (32,742) $ 11,350 $ (48,930) $ 12,924 (143,152) [1] 84,888 [1] $ (27,563) [2] $ (57,398) [2] $ 182,196 [2]
Received net cash settlements                   $ (54,056) $ 13,668 $ 23,834 $ 172,182 $ 181,927
[1] The Company paid $33.6 million and received $9.2 million in net cash settlements for the three months ended June 30, 2018 and 2017, respectively, and paid $54.1 million and received $13.7 million in net cash settlements for the six months ended June 30, 2018 and 2017, respectively.
[2] The Company received net cash settlements of $23.8 million, $172.2 million and $181.9 million for the years ended December 31, 2017, 2016 and 2015, respectively.